BRPI0921692A2 - composto carbamato ou o sal do mesmo - Google Patents
composto carbamato ou o sal do mesmoInfo
- Publication number
- BRPI0921692A2 BRPI0921692A2 BRPI0921692-8A BRPI0921692A BRPI0921692A2 BR PI0921692 A2 BRPI0921692 A2 BR PI0921692A2 BR PI0921692 A BRPI0921692 A BR PI0921692A BR PI0921692 A2 BRPI0921692 A2 BR PI0921692A2
- Authority
- BR
- Brazil
- Prior art keywords
- faah
- inhibitory activity
- action
- ylcarbonyl
- piperazine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008-285466 | 2008-11-06 | ||
| JP2008285466 | 2008-11-06 | ||
| PCT/JP2009/068902 WO2010053120A1 (ja) | 2008-11-06 | 2009-11-05 | カルバメート化合物又はその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0921692A2 true BRPI0921692A2 (pt) | 2018-06-26 |
Family
ID=42152927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0921692-8A BRPI0921692A2 (pt) | 2008-11-06 | 2009-11-05 | composto carbamato ou o sal do mesmo |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110212973A1 (pt) |
| EP (1) | EP2351749A1 (pt) |
| JP (1) | JPWO2010053120A1 (pt) |
| KR (1) | KR20110091508A (pt) |
| CN (1) | CN102209718A (pt) |
| AU (1) | AU2009312032A1 (pt) |
| BR (1) | BRPI0921692A2 (pt) |
| CA (1) | CA2741500A1 (pt) |
| IL (1) | IL212403A0 (pt) |
| MX (1) | MX2011004704A (pt) |
| RU (1) | RU2011117927A (pt) |
| TW (1) | TW201031652A (pt) |
| WO (1) | WO2010053120A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011026241A1 (en) * | 2009-09-04 | 2011-03-10 | Zalicus Pharmaceuticals Ltd. | Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| JPWO2011078369A1 (ja) | 2009-12-25 | 2013-05-09 | 持田製薬株式会社 | 新規アリールウレア誘導体 |
| US20130150346A1 (en) | 2010-01-08 | 2013-06-13 | Quest Ventures Ltd. | Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome |
| WO2011123719A2 (en) | 2010-03-31 | 2011-10-06 | Ironwood Pharmaceuticals, Inc. | Use of faah inhibitors for treating abdominal, visceral and pelvic pain |
| JP2013147430A (ja) * | 2010-04-28 | 2013-08-01 | Astellas Pharma Inc | 夜間頻尿の予防又は治療剤 |
| TW201206440A (en) * | 2010-04-28 | 2012-02-16 | Astellas Pharma Inc | Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| WO2014134306A1 (en) | 2013-03-01 | 2014-09-04 | Zalicus Pharmaceuticals, Ltd. | Heterocyclic inhibitors of the sodium channel |
| BR112016027729B1 (pt) * | 2014-05-28 | 2020-11-17 | Astellas Pharma Inc. | composto derivado de piridina, composição farmacêutica contendo o referido composto e seu uso |
| AR102849A1 (es) * | 2015-03-09 | 2017-03-29 | Astellas Pharma Inc | Compuesto de piridina bicíclica |
| CN114478359B (zh) * | 2022-03-17 | 2023-09-29 | 河南大学 | 氨基甲酸酯类trpv1拮抗/faah抑制双靶点药物及其制备方法和应用 |
| CN121487920A (zh) * | 2023-07-18 | 2026-02-06 | 穆纳治疗有限公司 | Kv1.3钾通道拮抗剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003210824A1 (en) | 2002-02-08 | 2003-09-02 | Bristol-Myers Squibb Company | (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| MXPA05003715A (es) | 2002-10-07 | 2005-09-30 | Univ California | Modulacion de ansiedad a traves de bloqueo de hidrolisis de anandamida. |
| MX2007010076A (es) | 2005-02-17 | 2007-10-16 | Astellas Pharma Inc | Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo. |
| WO2008023720A1 (en) | 2006-08-23 | 2008-02-28 | Astellas Pharma Inc. | Urea compound or salt thereof |
-
2009
- 2009-11-05 RU RU2011117927/04A patent/RU2011117927A/ru unknown
- 2009-11-05 CN CN2009801444505A patent/CN102209718A/zh active Pending
- 2009-11-05 KR KR1020117010369A patent/KR20110091508A/ko not_active Withdrawn
- 2009-11-05 AU AU2009312032A patent/AU2009312032A1/en not_active Abandoned
- 2009-11-05 US US13/126,980 patent/US20110212973A1/en not_active Abandoned
- 2009-11-05 TW TW098137612A patent/TW201031652A/zh unknown
- 2009-11-05 CA CA2741500A patent/CA2741500A1/en not_active Abandoned
- 2009-11-05 BR BRPI0921692-8A patent/BRPI0921692A2/pt not_active IP Right Cessation
- 2009-11-05 EP EP09824819A patent/EP2351749A1/en not_active Withdrawn
- 2009-11-05 MX MX2011004704A patent/MX2011004704A/es not_active Application Discontinuation
- 2009-11-05 JP JP2010536783A patent/JPWO2010053120A1/ja not_active Withdrawn
- 2009-11-05 WO PCT/JP2009/068902 patent/WO2010053120A1/ja not_active Ceased
-
2011
- 2011-04-17 IL IL212403A patent/IL212403A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20110212973A1 (en) | 2011-09-01 |
| CA2741500A1 (en) | 2010-05-14 |
| JPWO2010053120A1 (ja) | 2012-04-05 |
| IL212403A0 (en) | 2011-06-30 |
| EP2351749A1 (en) | 2011-08-03 |
| TW201031652A (en) | 2010-09-01 |
| CN102209718A (zh) | 2011-10-05 |
| WO2010053120A1 (ja) | 2010-05-14 |
| RU2011117927A (ru) | 2012-12-20 |
| MX2011004704A (es) | 2011-05-30 |
| KR20110091508A (ko) | 2011-08-11 |
| AU2009312032A1 (en) | 2010-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006042150A8 (en) | Diaminoalkane aspartic protease inhibitors | |
| NO20074697L (no) | Ikke-aromatisk, nitrogenholdig heterosyklisk-1-karboksylatester-pyridylderivat | |
| WO2009093119A3 (en) | Use of serine protease inhibitors in the treatment of skin diseases | |
| NO20083032L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av mani og bipolar forstyrrelse | |
| RU2017127135A (ru) | Терапевтическое средство против рака желчных протоков | |
| HRP20120144T1 (en) | Therapeutic uses of compounds having combined sert, 5-ht3 and 5-ht1a activity | |
| HK1199726A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| WO2012104263A3 (en) | 1,4 oxazines as bace1 and/or bace2 inhibitors | |
| WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
| BR112014006763A2 (pt) | n-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexa-hidro-ciclopenta[e][1,3]oxazin-4-il)-fenil)-amidas como inibidores de bace1 | |
| EA200970435A1 (ru) | Лечение общих расстройств развития | |
| WO2007117557A3 (en) | Diaminopropanol renin inhibitors | |
| IL192100A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain | |
| HK1198619A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| NO20083033L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater som neurobeskyttende midler | |
| WO2007117560A8 (en) | Piperidine and morpholine renin inhibitors | |
| WO2009057685A1 (ja) | 過活動膀胱治療用医薬組成物 | |
| NZ602029A (en) | Use of meloxicam for the long-term treatment of kidney disorders in cats | |
| DK1569896T3 (da) | Tetrahydronaphthalenderivater | |
| WO2007117559A8 (en) | Renin inhibitors | |
| WO2008048648A3 (en) | Cb1-modulating compounds and their use | |
| ATE540690T1 (de) | Insulinkombinationen | |
| BR112014009165A8 (pt) | sal e uso médico | |
| BR112012026876A2 (pt) | agente para prevenção ou tratamento de doenças acompanhadas por dor urinária | |
| DK1732551T3 (da) | Perhexilin til behandling af kronisk hjertesvigt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2478 DE 03-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |